Long-Term Safety and Efficacy of Bremelanotide for Hypoactive Sexual Desire Disorder

To evaluate the long-term safety and efficacy of bremelanotide as treatment for hypoactive sexual desire disorder in premenopausal women. METHODS: Women who completed the 24-week double-blind core phase of RECONNECT, composed of two parallel phase 3 trials (301 and 302) examining the safety and effi...

Descripción completa

Detalles Bibliográficos
Autores principales: Simon, James A., Kingsberg, Sheryl A., Portman, David, Williams, Laura A., Krop, Julie, Jordan, Robert, Lucas, Johna, Clayton, Anita H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2019
Materias:
Contents
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6819023/
https://www.ncbi.nlm.nih.gov/pubmed/31599847
http://dx.doi.org/10.1097/AOG.0000000000003514

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6819023/
https://www.ncbi.nlm.nih.gov/pubmed/31599847
http://dx.doi.org/10.1097/AOG.0000000000003514

Ejemplares similares